• Investors
  • News
  • Subscribe
Hit enter to search or ESC to close
Cardax, Inc. | CDXI
  • About Us
    • Corporate Overview
    • Corporate Presentation
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Lead Scientific Team
    • Company History
  • Astaxanthin
    • Overview
      • Astaxanthin Overview
      • History and Background
      • Safety
      • Mechanism of Action
      • Synthetic vs. Natural Astaxanthin
    • Research in Key Addressable Markets
      • Cardiovascular Disease
      • Metabolic Disease
      • Liver Disease
      • Arthritis
      • Aging
      • Coronavirus Disease 2019 (COVID-19)
    • Scientific Literature
  • Programs
    • Product Platform
    • Commercialization Strategy
    • CDX-101
    • CDX-301
    • ZanthoSyn®
    • CHASE Clinical Trial
    • Intellectual Property
  • Newsroom
  • Investors
    • Investor Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Information
    • SEC Filings
    • Corporate Governance
  • Contact Us
Cardax, Inc. | CDXI
Mar 20 2020
0

Astaxanthin: A safe, natural, and multi-faceted anti-inflammatory for maintaining lung health and possibly minimizing SARS-CoV-2 effects

https://cardaxpharma.com/covid-19/
Jul 12 2017
2

The Secret to a Longer Life

https://cardaxpharma.com/wp-content/uploads/2017/07/MidWeek-Cover-Story_Cardax-UH-Longevity_2017-07-12.pdf
Jun 20 2017
1

NIH selection propels Cardax towards expansion

http://www.bizjournals.com/pacific/news/2017/06/20/nih-selection-propels-cardax-towards-expansion.html
Mar 29 2017
1

Compound boosts gene related to longevity, UH researchers find

https://cardaxpharma.com/wp-content/uploads/2017/03/Compound-Boosts-Gene-Related-to-Longevity-UH-Researchers-Find.pdf
Mar 28 2017
0

Promising anti-aging gene therapy developed through innovative partnership

http://www.hawaii.edu/news/2017/03/28/astaxanthin-therapy/
Mar 28 2017
0

Extending human life: UH scientists announce new research

http://www.kitv.com/story/35017622/extending-human-life-uh-scientists-announce-new-research
Mar 28 2017
0

UH study: Compound found in seafood, algae ‘activates’ longevity gene

http://www.hawaiinewsnow.com/story/35018512/study-compound-found-in-seafood-algae-activates-longevity-gene
Sep 27 2015
0

Hawaii Company Offers Solution to Chronic Pain [Star Advertiser]

https://cardaxpharma.com/wp-content/uploads/2015/09/Hawaii-Company-Offers-Solution-to-Chronic-Pain-Star-Advertiser.pdf
Jul 07 2015
1

Cardax Featured on Hawaii News Now [Video]

http://www.hawaiinewsnow.com/story/29494511/cardax-new-astaxanthin-consumer-health-product
Jun 30 2015
1

Hawaii-based Cardax Pharmaceuticals secures additional $500K for astaxanthin development

http://www.bizjournals.com/pacific/news/2015/06/30/hawaii-based-cardax-pharmaceuticals-secures.html
1 2 Next

About Cardax

Cardax is developing astaxanthin therapies for large unmet medical needs where inflammation and oxidative stress play key causative roles. Learn more >>

Recent News

  • Cardax Reports Q3 2020 Results November 13, 2020
  • Cardax Reports Q2 2020 Results August 14, 2020
  • Cardax Reports Q1 2020 Results May 15, 2020
  • Cardax Reports 2019 Annual Results March 30, 2020
Subscribe to Receive Updates by E-Mail Cardax News Alerts

Recent News

  • Cardax Reports Q3 2020 Results November 13, 2020
  • Cardax Reports Q2 2020 Results August 14, 2020
  • Cardax Reports Q1 2020 Results May 15, 2020

© 2020 Cardax, Inc. | Disclaimer and Terms of Use

  • About Us
    • Corporate Overview
    • Corporate Presentation
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Lead Scientific Team
    • Company History
  • Astaxanthin
    • Overview
      • Astaxanthin Overview
      • History and Background
      • Safety
      • Mechanism of Action
      • Synthetic vs. Natural Astaxanthin
    • Research in Key Addressable Markets
      • Cardiovascular Disease
      • Metabolic Disease
      • Liver Disease
      • Arthritis
      • Aging
      • Coronavirus Disease 2019 (COVID-19)
    • Scientific Literature
  • Programs
    • Product Platform
    • Commercialization Strategy
    • CDX-101
    • CDX-301
    • ZanthoSyn®
    • CHASE Clinical Trial
    • Intellectual Property
  • Newsroom
  • Investors
    • Investor Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Information
    • SEC Filings
    • Corporate Governance
  • Contact Us
  • Investors
  • News
  • Subscribe